CD59 and inflammatory bowel disease: Finally, although clinical trials testing the efficacy of diet supplementation with o-3 PUFA (DHA or EPA) in IBD have provided discordant results [95], the effect of specific pro-resolving molecules (i.e., maresins, resolvins, protectins) derived from DHA and EPA metabolism has not yet been tested in IBD patients.